静脉地塞米松减轻全膝关节置换术后12至21小时疼痛:双盲随机安慰剂对照试验
这项双盲随机安慰剂对照试验纳入单侧全膝关节置换患者,每臂50例,比较静脉地塞米松0.15 mg/kg与生理盐水安慰剂。结果显示地塞米松组在术后12、15、18、21小时的静息和运动疼痛评分均显著更低,恶心呕吐发生率更低,C反应蛋白水平更低;48小时吗啡消耗量、3个月功能评分和膝关节活动度无显著差异。
要点
- 静脉地塞米松0.15 mg/kg可降低全膝关节置换术后12至21小时的静息和运动疼痛评分。
- 地塞米松组恶心呕吐发生率29/50(58%)低于安慰剂组42/50(84%)(P = .008)。
- 地塞米松组C反应蛋白均值89 mg/L低于安慰剂组167 mg/L,差值-78 mg/L(95%CI -100至-58,P < .0001)。
核心结论
- 静脉地塞米松可缓解全膝关节置换术后12至21小时的疼痛,可能作为控制该类患者疼痛的有用辅助手段。
研究设计与样本
- 随机、双盲、安慰剂对照试验,比较单侧全膝关节置换术中静脉地塞米松0.15 mg/kg与生理盐水安慰剂,每臂招募50例患者。
主要发现
- 地塞米松组在术后12、15、18、21小时的静息和运动视觉模拟量表评分均显著低于安慰剂组(P < .05)。
- 术后21小时静息疼痛平均差值-11分(95%CI -21至-2分,P = .02),运动疼痛平均差值-15分(95%CI -25至-5分,P = .004)。
- 地塞米松组恶心呕吐发生率29/50(58%)低于安慰剂组42/50(84%)(P = .008)。
- 地塞米松组C反应蛋白均值89 mg/L低于安慰剂组167 mg/L,差值-78 mg/L(95%CI -100至-58 mg/L,P < .0001)。
- 48小时平均吗啡消耗量、3个月随访时改良WOMAC评分和膝关节活动度无显著差异(P > .05)。
关键数值与推荐
- 静脉地塞米松剂量为0.15 mg/kg。
- 主要结局为视觉模拟量表疼痛水平和术后48小时内吗啡消耗量(mg)。
- 术后21小时静息疼痛平均差值-11分(95%CI -21至-2分,P = .02),运动疼痛平均差值-15分(95%CI -25至-5分,P = .004)。
- 恶心呕吐发生率地塞米松组29/50(58%)vs 安慰剂组42/50(84%)(P = .008)。
- C反应蛋白均值地塞米松组89 mg/L vs 安慰剂组167 mg/L,差值-78 mg/L(95%CI -100至-58 mg/L,P < .0001)。
临床怎么用
- 静脉地塞米松0.15 mg/kg可在全膝关节置换术后12至21小时减轻静息和运动疼痛。
- 该方案可能与恶心呕吐发生率降低和C反应蛋白水平降低相关。
- 原文结论认为静脉地塞米松可能作为全膝关节置换患者疼痛控制的有用辅助手段。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pain after total knee arthroplasty (TKA) affects postoperative recovery and patient satisfaction. The analgesic benefits of corticosteroids have not been well studied. We, therefore, investigated the analgesic effects of intravenous (IV) dexamethasone (DEX) in patients undergoing a TKA. METHODS: This was a randomized, double-blind, placebo-controlled trial of 0.15 mg/kg of IV DEX vs saline placebo in unilateral TKA. Fifty patients/arm were recruited. Primary outcomes were pain level, determined by a visual analog scale, and the amount of morphine consumption (mg) ≤48 hours post-TKA. Secondary outcomes were rates of nausea and vomiting, C-reactive protein concentrations, and functional outcomes. RESULTS: The DEX group had a significantly lower mean visual analog scale score both at rest and during motion at 12, 15, 18, and 21 hours (P < .05). At 21 hours, the mean difference (Δ) in pain at rest was -11 points (95% confidence interval [CI], -21 to -2 points; P = .02) while the mean difference in pain during motion was -15 points (95% CI, -25 to -5 points; P = .004). The DEX group also had lower rates of nausea and vomiting: 29/50 (58%) vs 42/50 (84%) (P = .008) and lower mean C-reactive protein level: 89 vs 167, Δ = -78 mg/L (95% CI, -100 to -58 mg/L, P < .0001). There were no significant differences in mean morphine consumption by 48 hours, modified Western Ontario and McMaster University Osteoarthritis Index scores, and range of motion of the knee at 3-month follow-up (P > .05). CONCLUSION: IV DEX relieves postoperative pain between 12 to 21 hours after TKA and may be a useful adjunct for controlling pain in patients undergoing TKA.
引用
- Tammachote N, Kanitnate S. Intravenous Dexamethasone Injection Reduces Pain From 12 to 21 Hours After Total Knee Arthroplasty: A Double-Blind, Randomized, Placebo-Controlled Trial. J Arthroplasty. 2019. PMID: 31587982. doi:10.1016/j.arth.2019.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。